Literature DB >> 4451356

Pharmacokinetics of gentamicin and kanamycin during hemodialysis.

M Danish, R Schultz, W J Jusko.   

Abstract

The pharmacokinetics of gentamicin, kanamycin, and creatinine were studied in patients undergoing hemodialysis. After intravenous injection of single doses of the drugs, 50 to 60% of the doses of both antibiotics were cleared from the body during a 6-h period; this occurred almost entirely by the hemodialysis process. No correlation was found between the dialysance of the aminoglycosides and creatinine. The pharmacokinetic data were used to make dosage regimen recommendations for treatment of hemodialysis patients with these antibiotics.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4451356      PMCID: PMC444747          DOI: 10.1128/AAC.6.6.841

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Ampicillin and hetacillin pharmacokinetics in normal and anephric subjects.

Authors:  W J Jusko; G P Lewis; G W Schmitt
Journal:  Clin Pharmacol Ther       Date:  1973 Jan-Feb       Impact factor: 6.875

2.  Nomogram for kanamycin dosage.

Authors:  G E Mawer; S B Lucas; J G McGough
Journal:  Lancet       Date:  1972-07-01       Impact factor: 79.321

3.  Determination of serum creatinine by a direct colorimetric method.

Authors:  D Heinegård; G Tiderström
Journal:  Clin Chim Acta       Date:  1973-02-12       Impact factor: 3.786

4.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

5.  Correlation of serum creatinine concentration and gentamicin half-life.

Authors:  R E Cutler; A M Gyselynck; W P Fleet; A W Forrey
Journal:  JAMA       Date:  1972-02-21       Impact factor: 56.272

6.  Clinical research experience with gentamicin. Incidence of adverse reactions.

Authors:  G M Arcieri; F G Falco; H M Smith; L B Hobson
Journal:  Med J Aust       Date:  1970-06-13       Impact factor: 7.738

7.  Blood levels of ampicillin, kanamycin and gentamicin in the uremic patient.

Authors:  G Altmann; B Bogokowsky; G Boner; H E Eliahou
Journal:  Isr J Med Sci       Date:  1970 Nov-Dec

8.  Correlation of serum creatinine concentration and kanamycin half-life. Therapeutic implications.

Authors:  R E Cutler; B M Orme
Journal:  JAMA       Date:  1969-07-28       Impact factor: 56.272

9.  The relationship between kanamycin pharmacokinetics: distribution and renal function.

Authors:  B M Orme; R E Cutler
Journal:  Clin Pharmacol Ther       Date:  1969 Jul-Aug       Impact factor: 6.875

10.  Gentamicin therapy in renal failure: a nomogram for dosage.

Authors:  R A Chan; E J Benner; P D Hoeprich
Journal:  Ann Intern Med       Date:  1972-05       Impact factor: 25.391

View more
  13 in total

1.  Hemodialyzer clearances of gentamicin, kanamycin, tobramycin, amikacin, ethambutol, procainamide, and flucytosine, with a technique for planning therapy.

Authors:  T G Christopher; A D Blair; A W Forrey; R E Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

Review 2.  Pharmacokinetics and pharmacodynamics in critically ill patients.

Authors:  H J Mann; D W Fuhs; F B Cerra
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

Review 3.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

4.  Pharmacokinetics of intravenous amikacin after rapid and slow infusion with special reference to hemodialysis.

Authors:  J C Pechere; R Dugal; M M Pechere
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

5.  Pharmacokinetics of amikacin during hemodialysis and peritoneal dialysis.

Authors:  L Regeur; H Colding; H Jensen; J P Kampmann
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

6.  Elimination of ampicillin and gentamicin by hemofiltration.

Authors:  D Kraft; H Lode
Journal:  Klin Wochenschr       Date:  1979-02-15

7.  Hemodialysis elimination rates and clearance of gentamicin and tobramycin.

Authors:  G R Matzke; C E Halstenson; W F Keane
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

8.  Pharmacokinetics of gentamicin in hemodialysis patients: a comparative study between diabetic and non-diabetic patients.

Authors:  Mohammed A Al-Homrany; Yacoub M Irshaid; Assem K El Sherif; Haider A Omar
Journal:  Int Urol Nephrol       Date:  2008-09-03       Impact factor: 2.370

9.  Influence of hemodialysis on gentamicin pharmacokinetics, removal during hemodialysis, and recommended dosing.

Authors:  Kevin M Sowinski; Stephanie J Magner; Aroonrut Lucksiri; Meri K Scott; Richard J Hamburger; Bruce A Mueller
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 8.237

Review 10.  Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.

Authors:  C S Lee; T C Marbury
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.